◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Bronco Resources Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2025Jul 31, 2025 FY 2024Jul 31, 2024 FY 2023Jul 31, 2023 FY 2022Jul 31, 2022 FY 2021Jul 31, 2021
Total Revenue 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 --
Selling General And Administration 262,433 171,361 194,196 237,759 --
General And Administrative Expense 262,433 171,361 194,196 237,759 --
Other Operating Expenses -- -- -- -- 63,646
Operating Expense 262,433 171,361 194,734 237,759 --
Operating Income -262,433 -171,361 -194,734 -237,759 --
EBIT -262,433 -171,361 -194,734 -237,759 --
Interest Income 2,515 517.00 2,905 1,990 --
Interest Income Non Operating 2,515 517.00 2,905 1,990 --
Net Interest Income 2,515 517.00 2,905 1,990 --
Other Income Expense -- -271,724 1,002 18,441 --
Other Non Operating Income Expenses -- -- 1,002 18,441 --
Special Income Charges 0.00 -271,724 0.00 -- --
Pretax Income -259,918 -442,568 -190,827 -217,328 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -259,918 -442,568 -190,827 -217,328 --
Net Income From Continuing Operation Net Minority Interest -259,918 -442,568 -190,827 -217,328 --
Net Income Including Noncontrolling Interests -259,918 -442,568 -190,827 -217,328 --
Net Income Common Stockholders -259,918 -442,568 -190,827 -217,328 --
Net Income -259,918 -442,568 -190,827 -217,328 --
EBITDA -262,433 -171,361 -194,734 -237,759 --
Normalized EBITDA -262,433 100,363 -194,734 -237,759 --
Basic EPS -0.01 -0.02 -0.01 -0.01 --
Diluted EPS -0.01 -0.02 -0.01 -0.01 --
Basic Average Shares 27.1M 18.4M 18.0M 16.2M --
Diluted Average Shares 27.1M 18.4M 18.0M 16.2M --
Total Unusual Items 0.00 -271,724 0.00 -- --
Total Unusual Items Excluding Goodwill 0.00 -271,724 0.00 -- --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 --
Normalized Income -259,918 -170,844 -190,827 -217,328 --
Diluted NI Availto Com Stockholders -259,918 -442,568 -190,827 -217,328 --
Impairment Of Capital Assets 0.00 271,724 0.00 -- --
Insurance And Claims 0.00 12,889 10,154 11,307 --
Net Income Continuous Operations -259,918 -442,568 -190,827 -217,328 --
Net Non Operating Interest Income Expense 2,515 517.00 2,905 1,990 --
Other Gand A 184,759 153,472 174,542 182,950 --
Other Taxes -- 0.00 538.00 0.00 --
Rent And Landing Fees 0.00 5,000 9,500 14,052 --
Rent Expense Supplemental 0.00 5,000 9,500 14,052 --
Salaries And Wages 77,674 0.00 0.00 29,450 --
Total Expenses 262,433 171,361 194,734 237,759 --
Line Item FY 2025Jul 31, 2025 FY 2024Jul 31, 2024 FY 2023Jul 31, 2023 FY 2022Jul 31, 2022 FY 2021Jul 31, 2021
Cash And Cash Equivalents 89,867 14,699 29,810 298,495 --
Cash Cash Equivalents And Short Term Investments 89,867 14,699 29,810 298,495 --
Cash Financial 89,867 14,699 29,810 298,495 --
Accounts Receivable 1,651 1,808 1,873 54,710 --
Receivables 1,651 1,808 1,873 54,710 --
Prepaid Assets 644.00 489.00 1,114 1,019 --
Current Assets 92,162 16,996 32,797 363,237 --
Net PPE 2.8M 2.4M 2.7M 2.4M --
Other Non Current Assets 50,000 50,000 50,000 -- --
Total Non Current Assets 2.8M 2.4M 2.7M 2.4M --
Total Assets 2.9M 2.5M 2.7M 2.7M --
Accounts Payable 259,251 233,038 78,384 129,328 --
Payables 259,251 233,038 78,384 129,328 --
Payables And Accrued Expenses 259,251 233,038 78,384 129,328 --
Other Current Liabilities -- -- -- 1,002 --
Current Liabilities 259,251 233,038 78,384 130,330 --
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 --
Total Liabilities Net Minority Interest 259,251 233,038 78,384 130,330 --
Common Stock 35.5M 34.9M 34.9M 34.7M --
Capital Stock 35.5M 34.9M 34.9M 34.7M --
Additional Paid In Capital 1.7M 1.6M 1.6M 1.6M --
Retained Earnings -34.6M -34.3M -33.9M -33.7M --
Common Stock Equity 2.7M 2.2M 2.7M 2.6M --
Stockholders Equity 2.7M 2.2M 2.7M 2.6M --
Total Equity Gross Minority Interest 2.7M 2.2M 2.7M 2.6M --
Total Capitalization 2.7M 2.2M 2.7M 2.6M --
Net Tangible Assets 2.7M 2.2M 2.7M 2.6M --
Tangible Book Value 2.7M 2.2M 2.7M 2.6M --
Working Capital -167,089 -216,042 -45,587 232,907 --
Invested Capital 2.7M 2.2M 2.7M 2.6M --
Share Issued 29.5M 18.4M 18.4M 17.4M --
Ordinary Shares Number 29.5M 18.4M 18.4M 17.4M --
Restricted Cash -- -- 0.00 9,013 809,475
Treasury Shares Number -- 0.00 0.00 -- --
Line Item FY 2025Jul 31, 2025 FY 2024Jul 31, 2024 FY 2023Jul 31, 2023 FY 2022Jul 31, 2022 FY 2021Jul 31, 2021
Operating Cash Flow -157,293 -14,523 -117,458 -220,451 --
Cash Flow From Continuing Operating Activities -157,293 -14,523 -117,458 -220,451 --
Stock Based Compensation 77,674 0.00 0.00 29,450 --
Change In Working Capital 24,951 156,321 74,371 -14,132 --
Change In Receivables 157.00 65.00 52,837 -31,828 --
Change In Payables And Accrued Expense 24,949 155,631 21,629 2,422 --
Change In Payable 24,949 155,631 21,629 2,422 --
Other Non Cash Items -- -- -1,002 -18,441 --
Capital Expenditure -389,992 -588.00 -109,033 -946,114 --
Purchase Of PPE -389,992 -588.00 -109,033 -946,114 --
Net PPE Purchase And Sale -389,992 -588.00 -109,033 -946,114 --
Investing Cash Flow -389,992 -588.00 -159,033 -946,114 --
Cash Flow From Continuing Investing Activities -389,992 -588.00 -159,033 -946,114 --
Issuance Of Capital Stock 651,875 0.00 0.00 174,999 --
Net Common Stock Issuance 651,875 0.00 0.00 174,999 --
Financing Cash Flow 622,453 0.00 -1,207 168,101 --
Cash Flow From Continuing Financing Activities 622,453 0.00 -1,207 168,101 --
Changes In Cash 75,168 -15,111 -277,698 -998,464 --
Beginning Cash Position 14,699 29,810 307,508 1.3M --
End Cash Position 89,867 14,699 29,810 307,508 --
Free Cash Flow -547,285 -15,111 -226,491 -1.2M --
Asset Impairment Charge 0.00 271,724 -1,002 -- --
Change In Prepaid Assets -155.00 625.00 -95.00 15,274 --
Common Stock Issuance 651,875 0.00 0.00 174,999 --
Net Income From Continuing Operations -259,918 -442,568 -190,827 -217,328 --
Net Other Financing Charges -29,422 -- -1,207 -6,898 -95,396
Net Other Investing Changes -- -- -50,000 -- --
Proceeds From Stock Option Exercised -- -- -- -- 37,068
Sale Of PPE -- -588.00 -109,033 -- --
NEWS
Loading news...
TRENDING
Loading...